SIGA Technologies, Inc. (NASDAQ: SIGA) Stock Competitors & Peer Comparison
See SIGA's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for SIGA and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| SIGA | $2.91 | +0.87% | 205.8M | 10.63 | $0.27 | +20.65% |
| TAK | $17.42 | -0.37% | 55.4B | 12.52 | $1.39 | +3.62% |
| HLN | $9.79 | -1.51% | 43.2B | 18.28 | $0.54 | +1.80% |
| TEVA | $37.04 | +1.54% | 42.8B | 12.54 | $2.93 | N/A |
| VTRS | $16.25 | -0.16% | 18.7B | 6.39 | $2.52 | +2.98% |
| ITCI | $131.87 | +0.00% | 14B | -180.64 | -$0.73 | N/A |
| CTLT | $63.48 | +0.00% | 11.5B | -27.84 | -$2.28 | N/A |
| ELAN | $22.60 | -0.59% | 11.1B | 20.91 | $1.06 | N/A |
| RDY | $12.42 | -0.24% | 10.3B | 20.30 | $0.61 | +0.67% |
| LNTH | $100.90 | +0.22% | 6.6B | 16.93 | $5.95 | N/A |
Stock Comparison
Takeda Pharmaceutical Company Limited (NYSE: TAK)
SIGA vs TAK Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, TAK has a market cap of 55.4B. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while TAK trades at $17.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas TAK's P/E ratio is 12.52. In terms of profitability, SIGA's ROE is -0.02%, compared to TAK's ROE of +0.02%. Regarding short-term risk, SIGA is more volatile compared to TAK. This indicates higher risk in terms of short-term price fluctuations for SIGA.Check TAK's competition here
Haleon plc (NYSE: HLN)
SIGA vs HLN Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, HLN has a market cap of 43.2B. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while HLN trades at $9.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas HLN's P/E ratio is 18.28. In terms of profitability, SIGA's ROE is -0.02%, compared to HLN's ROE of +0.17%. Regarding short-term risk, SIGA is more volatile compared to HLN. This indicates higher risk in terms of short-term price fluctuations for SIGA.Check HLN's competition here
Teva Pharmaceutical Industries Limited (NYSE: TEVA)
SIGA vs TEVA Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, TEVA has a market cap of 42.8B. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while TEVA trades at $37.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas TEVA's P/E ratio is 12.54. In terms of profitability, SIGA's ROE is -0.02%, compared to TEVA's ROE of +0.09%. Regarding short-term risk, SIGA is more volatile compared to TEVA. This indicates higher risk in terms of short-term price fluctuations for SIGA.Check TEVA's competition here
Viatris Inc. (NASDAQ: VTRS)
SIGA vs VTRS Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, VTRS has a market cap of 18.7B. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while VTRS trades at $16.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas VTRS's P/E ratio is 6.39. In terms of profitability, SIGA's ROE is -0.02%, compared to VTRS's ROE of -0.03%. Regarding short-term risk, SIGA is more volatile compared to VTRS. This indicates higher risk in terms of short-term price fluctuations for SIGA.Check VTRS's competition here
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI)
SIGA vs ITCI Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, ITCI has a market cap of 14B. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while ITCI trades at $131.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas ITCI's P/E ratio is -180.64. In terms of profitability, SIGA's ROE is -0.02%, compared to ITCI's ROE of -0.09%. Regarding short-term risk, SIGA is more volatile compared to ITCI. This indicates higher risk in terms of short-term price fluctuations for SIGA.Check ITCI's competition here
Catalent, Inc. (NYSE: CTLT)
SIGA vs CTLT Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, CTLT has a market cap of 11.5B. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while CTLT trades at $63.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas CTLT's P/E ratio is -27.84. In terms of profitability, SIGA's ROE is -0.02%, compared to CTLT's ROE of -0.25%. Regarding short-term risk, SIGA is more volatile compared to CTLT. This indicates higher risk in terms of short-term price fluctuations for SIGA.Check CTLT's competition here
Elanco Animal Health Incorporated (NYSE: ELAN)
SIGA vs ELAN Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, ELAN has a market cap of 11.1B. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while ELAN trades at $22.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas ELAN's P/E ratio is 20.91. In terms of profitability, SIGA's ROE is -0.02%, compared to ELAN's ROE of -0.03%. Regarding short-term risk, SIGA is more volatile compared to ELAN. This indicates higher risk in terms of short-term price fluctuations for SIGA.Check ELAN's competition here
Dr. Reddy's Laboratories Limited (NYSE: RDY)
SIGA vs RDY Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, RDY has a market cap of 10.3B. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while RDY trades at $12.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas RDY's P/E ratio is 20.30. In terms of profitability, SIGA's ROE is -0.02%, compared to RDY's ROE of +0.09%. Regarding short-term risk, SIGA is more volatile compared to RDY. This indicates higher risk in terms of short-term price fluctuations for SIGA.Check RDY's competition here
Lantheus Holdings, Inc. (NASDAQ: LNTH)
SIGA vs LNTH Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, LNTH has a market cap of 6.6B. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while LNTH trades at $100.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas LNTH's P/E ratio is 16.93. In terms of profitability, SIGA's ROE is -0.02%, compared to LNTH's ROE of +0.23%. Regarding short-term risk, SIGA is more volatile compared to LNTH. This indicates higher risk in terms of short-term price fluctuations for SIGA.Check LNTH's competition here
Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX)
SIGA vs AMRX Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, AMRX has a market cap of 5.6B. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while AMRX trades at $17.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas AMRX's P/E ratio is 19.62. In terms of profitability, SIGA's ROE is -0.02%, compared to AMRX's ROE of -3.27%. Regarding short-term risk, SIGA is more volatile compared to AMRX. This indicates higher risk in terms of short-term price fluctuations for SIGA.Check AMRX's competition here
Indivior Pharmaceuticals Inc (NASDAQ: INDV)
SIGA vs INDV Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, INDV has a market cap of 4.8B. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while INDV trades at $38.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas INDV's P/E ratio is 10.61. In terms of profitability, SIGA's ROE is -0.02%, compared to INDV's ROE of -2.16%. Regarding short-term risk, SIGA is more volatile compared to INDV. This indicates higher risk in terms of short-term price fluctuations for SIGA.Check INDV's competition here
Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN)
SIGA vs SUPN Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, SUPN has a market cap of 2.8B. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while SUPN trades at $47.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas SUPN's P/E ratio is 15.64. In terms of profitability, SIGA's ROE is -0.02%, compared to SUPN's ROE of -0.10%. Regarding short-term risk, SIGA is more volatile compared to SUPN. This indicates higher risk in terms of short-term price fluctuations for SIGA.Check SUPN's competition here
Regencell Bioscience Holdings Limited (NASDAQ: RGC)
SIGA vs RGC Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, RGC has a market cap of 2.5B. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while RGC trades at $5.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas RGC's P/E ratio is -356.34. In terms of profitability, SIGA's ROE is -0.02%, compared to RGC's ROE of -2.32%. Regarding short-term risk, SIGA is more volatile compared to RGC. This indicates higher risk in terms of short-term price fluctuations for SIGA.Check RGC's competition here
Bausch Health Companies Inc. (NYSE: BHC)
SIGA vs BHC Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, BHC has a market cap of 2.3B. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while BHC trades at $6.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas BHC's P/E ratio is 1.58. In terms of profitability, SIGA's ROE is -0.02%, compared to BHC's ROE of +0.89%. Regarding short-term risk, SIGA is more volatile compared to BHC. This indicates higher risk in terms of short-term price fluctuations for SIGA.Check BHC's competition here
Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH)
SIGA vs DCPH Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, DCPH has a market cap of 2.2B. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while DCPH trades at $25.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas DCPH's P/E ratio is -11.58. In terms of profitability, SIGA's ROE is -0.02%, compared to DCPH's ROE of -0.56%. Regarding short-term risk, SIGA is more volatile compared to DCPH. This indicates higher risk in terms of short-term price fluctuations for SIGA.Check DCPH's competition here
HUTCHMED (China) Limited (NASDAQ: HCM)
SIGA vs HCM Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, HCM has a market cap of 2.1B. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while HCM trades at $12.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas HCM's P/E ratio is 4.59. In terms of profitability, SIGA's ROE is -0.02%, compared to HCM's ROE of +0.01%. Regarding short-term risk, SIGA is more volatile compared to HCM. This indicates higher risk in terms of short-term price fluctuations for SIGA.Check HCM's competition here
Avadel Pharmaceuticals plc (NASDAQ: AVDL)
SIGA vs AVDL Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, AVDL has a market cap of 2.1B. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while AVDL trades at $21.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas AVDL's P/E ratio is -1082.00. In terms of profitability, SIGA's ROE is -0.02%, compared to AVDL's ROE of +0.05%. Regarding short-term risk, SIGA is more volatile compared to AVDL. This indicates higher risk in terms of short-term price fluctuations for SIGA.Check AVDL's competition here
Embecta Corp. (NASDAQ: EMBCV)
SIGA vs EMBCV Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, EMBCV has a market cap of 1.9B. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while EMBCV trades at $33.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas EMBCV's P/E ratio is N/A. In terms of profitability, SIGA's ROE is -0.02%, compared to EMBCV's ROE of -0.19%. Regarding short-term risk, SIGA is less volatile compared to EMBCV. This indicates lower risk in terms of short-term price fluctuations for SIGA.Check EMBCV's competition here
Dynavax Technologies Corporation (NASDAQ: DVAX)
SIGA vs DVAX Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, DVAX has a market cap of 1.8B. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while DVAX trades at $15.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas DVAX's P/E ratio is -41.89. In terms of profitability, SIGA's ROE is -0.02%, compared to DVAX's ROE of -0.10%. Regarding short-term risk, SIGA is more volatile compared to DVAX. This indicates higher risk in terms of short-term price fluctuations for SIGA.Check DVAX's competition here
Perrigo Company plc (NYSE: PRGO)
SIGA vs PRGO Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, PRGO has a market cap of 1.8B. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while PRGO trades at $12.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas PRGO's P/E ratio is 5.07. In terms of profitability, SIGA's ROE is -0.02%, compared to PRGO's ROE of -0.56%. Regarding short-term risk, SIGA is less volatile compared to PRGO. This indicates lower risk in terms of short-term price fluctuations for SIGA.Check PRGO's competition here
ANI Pharmaceuticals, Inc. (NASDAQ: ANIP)
SIGA vs ANIP Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, ANIP has a market cap of 1.7B. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while ANIP trades at $75.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas ANIP's P/E ratio is 9.14. In terms of profitability, SIGA's ROE is -0.02%, compared to ANIP's ROE of +0.19%. Regarding short-term risk, SIGA is more volatile compared to ANIP. This indicates higher risk in terms of short-term price fluctuations for SIGA.Check ANIP's competition here
Taro Pharmaceutical Industries Ltd. (NYSE: TARO)
SIGA vs TARO Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, TARO has a market cap of 1.6B. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while TARO trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas TARO's P/E ratio is 30.05. In terms of profitability, SIGA's ROE is -0.02%, compared to TARO's ROE of +0.03%. Regarding short-term risk, SIGA is more volatile compared to TARO. This indicates higher risk in terms of short-term price fluctuations for SIGA.Check TARO's competition here
Harrow Health, Inc. (NASDAQ: HROW)
SIGA vs HROW Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, HROW has a market cap of 1.5B. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while HROW trades at $39.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas HROW's P/E ratio is 437.33. In terms of profitability, SIGA's ROE is -0.02%, compared to HROW's ROE of -1.04%. Regarding short-term risk, SIGA is less volatile compared to HROW. This indicates lower risk in terms of short-term price fluctuations for SIGA.Check HROW's competition here
Phibro Animal Health Corporation (NASDAQ: PAHC)
SIGA vs PAHC Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, PAHC has a market cap of 1.4B. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while PAHC trades at $34.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas PAHC's P/E ratio is 11.54. In terms of profitability, SIGA's ROE is -0.02%, compared to PAHC's ROE of +0.29%. Regarding short-term risk, SIGA is more volatile compared to PAHC. This indicates higher risk in terms of short-term price fluctuations for SIGA.Check PAHC's competition here
Alvotech (NASDAQ: ALVO)
SIGA vs ALVO Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, ALVO has a market cap of 1.4B. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while ALVO trades at $3.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas ALVO's P/E ratio is -11.79. In terms of profitability, SIGA's ROE is -0.02%, compared to ALVO's ROE of +0.35%. Regarding short-term risk, SIGA is less volatile compared to ALVO. This indicates lower risk in terms of short-term price fluctuations for SIGA.Check ALVO's competition here
Cronos Group Inc. (NASDAQ: CRON)
SIGA vs CRON Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, CRON has a market cap of 1.2B. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while CRON trades at $3.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas CRON's P/E ratio is 30.10. In terms of profitability, SIGA's ROE is -0.02%, compared to CRON's ROE of +0.06%. Regarding short-term risk, SIGA is less volatile compared to CRON. This indicates lower risk in terms of short-term price fluctuations for SIGA.Check CRON's competition here
Eton Pharmaceuticals, Inc. (NASDAQ: ETON)
SIGA vs ETON Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, ETON has a market cap of 1.1B. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while ETON trades at $42.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas ETON's P/E ratio is -594.00. In terms of profitability, SIGA's ROE is -0.02%, compared to ETON's ROE of -0.06%. Regarding short-term risk, SIGA is less volatile compared to ETON. This indicates lower risk in terms of short-term price fluctuations for SIGA.Check ETON's competition here
Pacira BioSciences, Inc. (NASDAQ: PCRX)
SIGA vs PCRX Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, PCRX has a market cap of 932.2M. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while PCRX trades at $23.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas PCRX's P/E ratio is 9.12. In terms of profitability, SIGA's ROE is -0.02%, compared to PCRX's ROE of +0.02%. Regarding short-term risk, SIGA is more volatile compared to PCRX. This indicates higher risk in terms of short-term price fluctuations for SIGA.Check PCRX's competition here
PetIQ, Inc. (NASDAQ: PETQ)
SIGA vs PETQ Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, PETQ has a market cap of 919.2M. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while PETQ trades at $30.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas PETQ's P/E ratio is 83.73. In terms of profitability, SIGA's ROE is -0.02%, compared to PETQ's ROE of +0.01%. Regarding short-term risk, SIGA is more volatile compared to PETQ. This indicates higher risk in terms of short-term price fluctuations for SIGA.Check PETQ's competition here
Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH)
SIGA vs AMPH Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, AMPH has a market cap of 881M. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while AMPH trades at $20.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas AMPH's P/E ratio is 6.82. In terms of profitability, SIGA's ROE is -0.02%, compared to AMPH's ROE of +0.10%. Regarding short-term risk, SIGA is more volatile compared to AMPH. This indicates higher risk in terms of short-term price fluctuations for SIGA.Check AMPH's competition here
Collegium Pharmaceutical, Inc. (NASDAQ: COLL)
SIGA vs COLL Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, COLL has a market cap of 842.6M. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while COLL trades at $28.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas COLL's P/E ratio is 3.26. In terms of profitability, SIGA's ROE is -0.02%, compared to COLL's ROE of +0.16%. Regarding short-term risk, SIGA is more volatile compared to COLL. This indicates higher risk in terms of short-term price fluctuations for SIGA.Check COLL's competition here
Evotec SE (NASDAQ: EVO)
SIGA vs EVO Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, EVO has a market cap of 778M. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while EVO trades at $2.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas EVO's P/E ratio is -3.09. In terms of profitability, SIGA's ROE is -0.02%, compared to EVO's ROE of -0.24%. Regarding short-term risk, SIGA is more volatile compared to EVO. This indicates higher risk in terms of short-term price fluctuations for SIGA.Check EVO's competition here
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD)
SIGA vs IRWD Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, IRWD has a market cap of 711.1M. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while IRWD trades at $4.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas IRWD's P/E ratio is 5.54. In terms of profitability, SIGA's ROE is -0.02%, compared to IRWD's ROE of -0.57%. Regarding short-term risk, SIGA is less volatile compared to IRWD. This indicates lower risk in terms of short-term price fluctuations for SIGA.Check IRWD's competition here
BioDelivery Sciences International, Inc. (NASDAQ: BDSI)
SIGA vs BDSI Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, BDSI has a market cap of 577.1M. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while BDSI trades at $5.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas BDSI's P/E ratio is 6.82. In terms of profitability, SIGA's ROE is -0.02%, compared to BDSI's ROE of +0.57%. Regarding short-term risk, SIGA is more volatile compared to BDSI. This indicates higher risk in terms of short-term price fluctuations for SIGA.Check BDSI's competition here
Evolus, Inc. (NASDAQ: EOLS)
SIGA vs EOLS Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, EOLS has a market cap of 534.7M. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while EOLS trades at $8.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas EOLS's P/E ratio is -25.71. In terms of profitability, SIGA's ROE is -0.02%, compared to EOLS's ROE of +1.23%. Regarding short-term risk, SIGA is more volatile compared to EOLS. This indicates higher risk in terms of short-term price fluctuations for SIGA.Check EOLS's competition here
Aquestive Therapeutics, Inc. (NASDAQ: AQST)
SIGA vs AQST Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, AQST has a market cap of 530.7M. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while AQST trades at $4.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas AQST's P/E ratio is -6.93. In terms of profitability, SIGA's ROE is -0.02%, compared to AQST's ROE of +2.44%. Regarding short-term risk, SIGA is less volatile compared to AQST. This indicates lower risk in terms of short-term price fluctuations for SIGA.Check AQST's competition here
Tilray Brands, Inc. (NASDAQ: TLRY)
SIGA vs TLRY Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, TLRY has a market cap of 523.4M. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while TLRY trades at $4.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas TLRY's P/E ratio is -4.32. In terms of profitability, SIGA's ROE is -0.02%, compared to TLRY's ROE of -0.08%. Regarding short-term risk, SIGA is less volatile compared to TLRY. This indicates lower risk in terms of short-term price fluctuations for SIGA.Check TLRY's competition here
Canopy Growth Corporation (NASDAQ: CGC)
SIGA vs CGC Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, CGC has a market cap of 432.7M. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while CGC trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas CGC's P/E ratio is -0.62. In terms of profitability, SIGA's ROE is -0.02%, compared to CGC's ROE of -0.33%. Regarding short-term risk, SIGA is more volatile compared to CGC. This indicates higher risk in terms of short-term price fluctuations for SIGA.Check CGC's competition here
Kamada Ltd. (NASDAQ: KMDA)
SIGA vs KMDA Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, KMDA has a market cap of 396.9M. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while KMDA trades at $7.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas KMDA's P/E ratio is 19.66. In terms of profitability, SIGA's ROE is -0.02%, compared to KMDA's ROE of +0.08%. Regarding short-term risk, SIGA is less volatile compared to KMDA. This indicates lower risk in terms of short-term price fluctuations for SIGA.Check KMDA's competition here
Alpha Teknova, Inc. (NASDAQ: TKNO)
SIGA vs TKNO Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, TKNO has a market cap of 396.2M. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while TKNO trades at $7.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas TKNO's P/E ratio is -23.84. In terms of profitability, SIGA's ROE is -0.02%, compared to TKNO's ROE of -0.25%. Regarding short-term risk, SIGA is less volatile compared to TKNO. This indicates lower risk in terms of short-term price fluctuations for SIGA.Check TKNO's competition here
Alimera Sciences, Inc. (NASDAQ: ALIM)
SIGA vs ALIM Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, ALIM has a market cap of 301.3M. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while ALIM trades at $5.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas ALIM's P/E ratio is 5.28. In terms of profitability, SIGA's ROE is -0.02%, compared to ALIM's ROE of -1.59%. Regarding short-term risk, SIGA is more volatile compared to ALIM. This indicates higher risk in terms of short-term price fluctuations for SIGA.Check ALIM's competition here
Embecta Corp. (NASDAQ: EMBC)
SIGA vs EMBC Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, EMBC has a market cap of 281.8M. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while EMBC trades at $5.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas EMBC's P/E ratio is 1.83. In terms of profitability, SIGA's ROE is -0.02%, compared to EMBC's ROE of -0.14%. Regarding short-term risk, SIGA is less volatile compared to EMBC. This indicates lower risk in terms of short-term price fluctuations for SIGA.Check EMBC's competition here
Landec Corporation (NASDAQ: LNDC)
SIGA vs LNDC Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, LNDC has a market cap of 263.6M. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while LNDC trades at $8.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas LNDC's P/E ratio is -4.04. In terms of profitability, SIGA's ROE is -0.02%, compared to LNDC's ROE of +6.44%. Regarding short-term risk, SIGA is more volatile compared to LNDC. This indicates higher risk in terms of short-term price fluctuations for SIGA.Check LNDC's competition here
Aurora Cannabis Inc. (NASDAQ: ACB)
SIGA vs ACB Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, ACB has a market cap of 236.6M. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while ACB trades at $3.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas ACB's P/E ratio is -7.80. In terms of profitability, SIGA's ROE is -0.02%, compared to ACB's ROE of -0.21%. Regarding short-term risk, SIGA is less volatile compared to ACB. This indicates lower risk in terms of short-term price fluctuations for SIGA.Check ACB's competition here
Organogenesis Holdings Inc. (NASDAQ: ORGO)
SIGA vs ORGO Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, ORGO has a market cap of 232.9M. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while ORGO trades at $1.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas ORGO's P/E ratio is 60.33. In terms of profitability, SIGA's ROE is -0.02%, compared to ORGO's ROE of -0.24%. Regarding short-term risk, SIGA is less volatile compared to ORGO. This indicates lower risk in terms of short-term price fluctuations for SIGA.Check ORGO's competition here
Shineco, Inc. (NASDAQ: TYHT)
SIGA vs TYHT Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, TYHT has a market cap of 229.2M. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while TYHT trades at $11.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas TYHT's P/E ratio is -1.61. In terms of profitability, SIGA's ROE is -0.02%, compared to TYHT's ROE of -0.57%. Regarding short-term risk, SIGA is less volatile compared to TYHT. This indicates lower risk in terms of short-term price fluctuations for SIGA.Check TYHT's competition here
Organigram Global Inc. (NASDAQ: OGI)
SIGA vs OGI Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, OGI has a market cap of 181.6M. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while OGI trades at $1.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas OGI's P/E ratio is -4.96. In terms of profitability, SIGA's ROE is -0.02%, compared to OGI's ROE of -0.07%. Regarding short-term risk, SIGA is more volatile compared to OGI. This indicates higher risk in terms of short-term price fluctuations for SIGA.Check OGI's competition here
Lifecore Biomedical, Inc. (NASDAQ: LFCR)
SIGA vs LFCR Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, LFCR has a market cap of 178.9M. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while LFCR trades at $4.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas LFCR's P/E ratio is -4.46. In terms of profitability, SIGA's ROE is -0.02%, compared to LFCR's ROE of -2.51%. Regarding short-term risk, SIGA is more volatile compared to LFCR. This indicates higher risk in terms of short-term price fluctuations for SIGA.Check LFCR's competition here
Recro Pharma, Inc. (NASDAQ: REPH)
SIGA vs REPH Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, REPH has a market cap of 177.4M. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while REPH trades at $2.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas REPH's P/E ratio is -8.04. In terms of profitability, SIGA's ROE is -0.02%, compared to REPH's ROE of -0.22%. Regarding short-term risk, SIGA is less volatile compared to REPH. This indicates lower risk in terms of short-term price fluctuations for SIGA.Check REPH's competition here
Journey Medical Corporation (NASDAQ: DERM)
SIGA vs DERM Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, DERM has a market cap of 177M. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while DERM trades at $6.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas DERM's P/E ratio is -17.38. In terms of profitability, SIGA's ROE is -0.02%, compared to DERM's ROE of -0.36%. Regarding short-term risk, SIGA is less volatile compared to DERM. This indicates lower risk in terms of short-term price fluctuations for SIGA.Check DERM's competition here
Cardiol Therapeutics Inc. (NASDAQ: CRDL)
SIGA vs CRDL Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, CRDL has a market cap of 175.2M. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while CRDL trades at $1.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas CRDL's P/E ratio is -5.41. In terms of profitability, SIGA's ROE is -0.02%, compared to CRDL's ROE of -2.29%. Regarding short-term risk, SIGA is less volatile compared to CRDL. This indicates lower risk in terms of short-term price fluctuations for SIGA.Check CRDL's competition here
Theratechnologies Inc. (NASDAQ: THTX)
SIGA vs THTX Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, THTX has a market cap of 155.9M. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while THTX trades at $3.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas THTX's P/E ratio is -28.83. In terms of profitability, SIGA's ROE is -0.02%, compared to THTX's ROE of +0.17%. Regarding short-term risk, SIGA is more volatile compared to THTX. This indicates higher risk in terms of short-term price fluctuations for SIGA.Check THTX's competition here
Assertio Holdings, Inc. (NASDAQ: ASRT)
SIGA vs ASRT Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, ASRT has a market cap of 151.9M. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while ASRT trades at $23.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas ASRT's P/E ratio is -7.10. In terms of profitability, SIGA's ROE is -0.02%, compared to ASRT's ROE of -0.39%. Regarding short-term risk, SIGA is more volatile compared to ASRT. This indicates higher risk in terms of short-term price fluctuations for SIGA.Check ASRT's competition here
Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX)
SIGA vs CPIX Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, CPIX has a market cap of 119.3M. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while CPIX trades at $7.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas CPIX's P/E ratio is -19.90. In terms of profitability, SIGA's ROE is -0.02%, compared to CPIX's ROE of -0.47%. Regarding short-term risk, SIGA is less volatile compared to CPIX. This indicates lower risk in terms of short-term price fluctuations for SIGA.Check CPIX's competition here
Societal CDMO, Inc. (NASDAQ: SCTL)
SIGA vs SCTL Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, SCTL has a market cap of 116.1M. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while SCTL trades at $1.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas SCTL's P/E ratio is -7.86. In terms of profitability, SIGA's ROE is -0.02%, compared to SCTL's ROE of -0.22%. Regarding short-term risk, SIGA is more volatile compared to SCTL. This indicates higher risk in terms of short-term price fluctuations for SIGA.Check SCTL's competition here
BGM Group Ltd. (NASDAQ: BGM)
SIGA vs BGM Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, BGM has a market cap of 111.9M. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while BGM trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas BGM's P/E ratio is -1.01. In terms of profitability, SIGA's ROE is -0.02%, compared to BGM's ROE of -0.07%. Regarding short-term risk, SIGA is less volatile compared to BGM. This indicates lower risk in terms of short-term price fluctuations for SIGA.Check BGM's competition here
Procaps Group S.A. (NASDAQ: PROC)
SIGA vs PROC Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, PROC has a market cap of 102.1M. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while PROC trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas PROC's P/E ratio is 1.53. In terms of profitability, SIGA's ROE is -0.02%, compared to PROC's ROE of -2.22%. Regarding short-term risk, SIGA is more volatile compared to PROC. This indicates higher risk in terms of short-term price fluctuations for SIGA.Check PROC's competition here
OptiNose, Inc. (NASDAQ: OPTN)
SIGA vs OPTN Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, OPTN has a market cap of 97.2M. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while OPTN trades at $9.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas OPTN's P/E ratio is -4.42. In terms of profitability, SIGA's ROE is -0.02%, compared to OPTN's ROE of +0.34%. Regarding short-term risk, SIGA is more volatile compared to OPTN. This indicates higher risk in terms of short-term price fluctuations for SIGA.Check OPTN's competition here
Zomedica Corp. (AMEX: ZOM)
SIGA vs ZOM Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, ZOM has a market cap of 95.3M. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while ZOM trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas ZOM's P/E ratio is -1.62. In terms of profitability, SIGA's ROE is -0.02%, compared to ZOM's ROE of -0.17%. Regarding short-term risk, SIGA is less volatile compared to ZOM. This indicates lower risk in terms of short-term price fluctuations for SIGA.Check ZOM's competition here
Upexi, Inc. (NASDAQ: GRVI)
SIGA vs GRVI Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, GRVI has a market cap of 88.9M. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while GRVI trades at $4.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas GRVI's P/E ratio is 26.05. In terms of profitability, SIGA's ROE is -0.02%, compared to GRVI's ROE of -2.54%. Regarding short-term risk, SIGA is less volatile compared to GRVI. This indicates lower risk in terms of short-term price fluctuations for SIGA.Check GRVI's competition here
Zhengye Biotechnology Holding Limited (NASDAQ: ZYBT)
SIGA vs ZYBT Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, ZYBT has a market cap of 73.5M. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while ZYBT trades at $1.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas ZYBT's P/E ratio is -7.05. In terms of profitability, SIGA's ROE is -0.02%, compared to ZYBT's ROE of -0.27%. Regarding short-term risk, SIGA is less volatile compared to ZYBT. This indicates lower risk in terms of short-term price fluctuations for SIGA.Check ZYBT's competition here
Talphera, Inc. (NASDAQ: TLPH)
SIGA vs TLPH Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, TLPH has a market cap of 72.7M. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while TLPH trades at $1.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas TLPH's P/E ratio is -4.52. In terms of profitability, SIGA's ROE is -0.02%, compared to TLPH's ROE of -0.93%. Regarding short-term risk, SIGA is less volatile compared to TLPH. This indicates lower risk in terms of short-term price fluctuations for SIGA.Check TLPH's competition here
Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE)
SIGA vs ZYNE Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, ZYNE has a market cap of 70.1M. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while ZYNE trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas ZYNE's P/E ratio is -1.65. In terms of profitability, SIGA's ROE is -0.02%, compared to ZYNE's ROE of -0.59%. Regarding short-term risk, SIGA is less volatile compared to ZYNE. This indicates lower risk in terms of short-term price fluctuations for SIGA.Check ZYNE's competition here
Silver Spike Investment Corp. (NASDAQ: SSIC)
SIGA vs SSIC Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, SSIC has a market cap of 66.7M. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while SSIC trades at $10.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas SSIC's P/E ratio is 11.93. In terms of profitability, SIGA's ROE is -0.02%, compared to SSIC's ROE of +0.00%. Regarding short-term risk, SIGA is more volatile compared to SSIC. This indicates higher risk in terms of short-term price fluctuations for SIGA.Check SSIC's competition here
The Valens Company Inc. (NASDAQ: VLNS)
SIGA vs VLNS Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, VLNS has a market cap of 61.5M. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while VLNS trades at $0.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas VLNS's P/E ratio is -1.03. In terms of profitability, SIGA's ROE is -0.02%, compared to VLNS's ROE of N/A. Regarding short-term risk, SIGA is less volatile compared to VLNS. This indicates lower risk in terms of short-term price fluctuations for SIGA.Check VLNS's competition here
DURECT Corporation (NASDAQ: DRRX)
SIGA vs DRRX Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, DRRX has a market cap of 59.3M. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while DRRX trades at $1.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas DRRX's P/E ratio is -4.44. In terms of profitability, SIGA's ROE is -0.02%, compared to DRRX's ROE of -1.40%. Regarding short-term risk, SIGA is more volatile compared to DRRX. This indicates higher risk in terms of short-term price fluctuations for SIGA.Check DRRX's competition here
InterCure Ltd. (NASDAQ: INCR)
SIGA vs INCR Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, INCR has a market cap of 57.1M. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while INCR trades at $0.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas INCR's P/E ratio is -2.23. In terms of profitability, SIGA's ROE is -0.02%, compared to INCR's ROE of -0.09%. Regarding short-term risk, SIGA is less volatile compared to INCR. This indicates lower risk in terms of short-term price fluctuations for SIGA.Check INCR's competition here
Jupiter Wellness, Inc. (NASDAQ: JUPW)
SIGA vs JUPW Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, JUPW has a market cap of 49.3M. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while JUPW trades at $1.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas JUPW's P/E ratio is -2.41. In terms of profitability, SIGA's ROE is -0.02%, compared to JUPW's ROE of -1.94%. Regarding short-term risk, SIGA is less volatile compared to JUPW. This indicates lower risk in terms of short-term price fluctuations for SIGA.Check JUPW's competition here
China Pharma Holdings, Inc. (AMEX: CPHI)
SIGA vs CPHI Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, CPHI has a market cap of 44.6M. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while CPHI trades at $1.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas CPHI's P/E ratio is -1.72. In terms of profitability, SIGA's ROE is -0.02%, compared to CPHI's ROE of -0.19%. Regarding short-term risk, SIGA is less volatile compared to CPHI. This indicates lower risk in terms of short-term price fluctuations for SIGA.Check CPHI's competition here
Qilian International Holding Group Limited (NASDAQ: QLI)
SIGA vs QLI Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, QLI has a market cap of 38.7M. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while QLI trades at $5.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas QLI's P/E ratio is -4.92. In terms of profitability, SIGA's ROE is -0.02%, compared to QLI's ROE of -0.16%. Regarding short-term risk, SIGA is more volatile compared to QLI. This indicates higher risk in terms of short-term price fluctuations for SIGA.Check QLI's competition here
HEXO Corp. (NASDAQ: HEXO)
SIGA vs HEXO Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, HEXO has a market cap of 31.2M. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while HEXO trades at $0.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas HEXO's P/E ratio is -0.26. In terms of profitability, SIGA's ROE is -0.02%, compared to HEXO's ROE of -2.06%. Regarding short-term risk, SIGA is less volatile compared to HEXO. This indicates lower risk in terms of short-term price fluctuations for SIGA.Check HEXO's competition here
Rockwell Medical, Inc. (NASDAQ: RMTI)
SIGA vs RMTI Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, RMTI has a market cap of 30.8M. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while RMTI trades at $7.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas RMTI's P/E ratio is -7.42. In terms of profitability, SIGA's ROE is -0.02%, compared to RMTI's ROE of -0.15%. Regarding short-term risk, SIGA is less volatile compared to RMTI. This indicates lower risk in terms of short-term price fluctuations for SIGA.Check RMTI's competition here
Aytu BioPharma, Inc. (NASDAQ: AYTU)
SIGA vs AYTU Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, AYTU has a market cap of 25.3M. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while AYTU trades at $2.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas AYTU's P/E ratio is -1.23. In terms of profitability, SIGA's ROE is -0.02%, compared to AYTU's ROE of -1.49%. Regarding short-term risk, SIGA is more volatile compared to AYTU. This indicates higher risk in terms of short-term price fluctuations for SIGA.Check AYTU's competition here
TherapeuticsMD, Inc. (NASDAQ: TXMD)
SIGA vs TXMD Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, TXMD has a market cap of 24.1M. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while TXMD trades at $2.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas TXMD's P/E ratio is 105.96. In terms of profitability, SIGA's ROE is -0.02%, compared to TXMD's ROE of -0.01%. Regarding short-term risk, SIGA is more volatile compared to TXMD. This indicates higher risk in terms of short-term price fluctuations for SIGA.Check TXMD's competition here
Cyclo Therapeutics, Inc. (NASDAQ: CYTH)
SIGA vs CYTH Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, CYTH has a market cap of 23.6M. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while CYTH trades at $0.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas CYTH's P/E ratio is -0.80. In terms of profitability, SIGA's ROE is -0.02%, compared to CYTH's ROE of -7.30%. Regarding short-term risk, SIGA is more volatile compared to CYTH. This indicates higher risk in terms of short-term price fluctuations for SIGA.Check CYTH's competition here
Evoke Pharma, Inc. (NASDAQ: EVOK)
SIGA vs EVOK Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, EVOK has a market cap of 18.9M. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while EVOK trades at $11.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas EVOK's P/E ratio is -7.97. In terms of profitability, SIGA's ROE is -0.02%, compared to EVOK's ROE of -0.89%. Regarding short-term risk, SIGA is more volatile compared to EVOK. This indicates higher risk in terms of short-term price fluctuations for SIGA.Check EVOK's competition here
Optimi Health Corp. (NASDAQ: OPTH)
SIGA vs OPTH Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, OPTH has a market cap of 15.3M. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while OPTH trades at $4.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas OPTH's P/E ratio is -17.38. In terms of profitability, SIGA's ROE is -0.02%, compared to OPTH's ROE of -0.94%. Regarding short-term risk, SIGA is less volatile compared to OPTH. This indicates lower risk in terms of short-term price fluctuations for SIGA.Check OPTH's competition here
AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX)
SIGA vs ACRX Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, ACRX has a market cap of 14.6M. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while ACRX trades at $0.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas ACRX's P/E ratio is -0.31. In terms of profitability, SIGA's ROE is -0.02%, compared to ACRX's ROE of -0.93%. Regarding short-term risk, SIGA is less volatile compared to ACRX. This indicates lower risk in terms of short-term price fluctuations for SIGA.Check ACRX's competition here
Biofrontera Inc. (NASDAQ: BFRIW)
SIGA vs BFRIW Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, BFRIW has a market cap of 13.3M. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while BFRIW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas BFRIW's P/E ratio is -0.02. In terms of profitability, SIGA's ROE is -0.02%, compared to BFRIW's ROE of -4.77%. Regarding short-term risk, SIGA is less volatile compared to BFRIW. This indicates lower risk in terms of short-term price fluctuations for SIGA.Check BFRIW's competition here
Cosmos Health Inc. (NASDAQ: COSM)
SIGA vs COSM Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, COSM has a market cap of 11.7M. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while COSM trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas COSM's P/E ratio is -0.29. In terms of profitability, SIGA's ROE is -0.02%, compared to COSM's ROE of -0.96%. Regarding short-term risk, SIGA is more volatile compared to COSM. This indicates higher risk in terms of short-term price fluctuations for SIGA.Check COSM's competition here
Agile Therapeutics, Inc. (NASDAQ: AGRX)
SIGA vs AGRX Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, AGRX has a market cap of 10.4M. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while AGRX trades at $1.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas AGRX's P/E ratio is -0.89. In terms of profitability, SIGA's ROE is -0.02%, compared to AGRX's ROE of +1.32%. Regarding short-term risk, SIGA is less volatile compared to AGRX. This indicates lower risk in terms of short-term price fluctuations for SIGA.Check AGRX's competition here
Neoleukin Therapeutics, Inc. (NASDAQ: NLTX)
SIGA vs NLTX Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, NLTX has a market cap of 8.2M. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while NLTX trades at $3.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas NLTX's P/E ratio is -0.28. In terms of profitability, SIGA's ROE is -0.02%, compared to NLTX's ROE of -0.45%. Regarding short-term risk, SIGA is less volatile compared to NLTX. This indicates lower risk in terms of short-term price fluctuations for SIGA.Check NLTX's competition here
Lannett Company, Inc. (NYSE: LCI)
SIGA vs LCI Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, LCI has a market cap of 7.4M. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while LCI trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas LCI's P/E ratio is -0.04. In terms of profitability, SIGA's ROE is -0.02%, compared to LCI's ROE of +1.66%. Regarding short-term risk, SIGA is less volatile compared to LCI. This indicates lower risk in terms of short-term price fluctuations for SIGA.Check LCI's competition here
Adamis Pharmaceuticals Corporation (NASDAQ: ADMP)
SIGA vs ADMP Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, ADMP has a market cap of 7.3M. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while ADMP trades at $0.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas ADMP's P/E ratio is -0.08. In terms of profitability, SIGA's ROE is -0.02%, compared to ADMP's ROE of -2.09%. Regarding short-term risk, SIGA is less volatile compared to ADMP. This indicates lower risk in terms of short-term price fluctuations for SIGA.Check ADMP's competition here
cbdMD, Inc. (AMEX: YCBD)
SIGA vs YCBD Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, YCBD has a market cap of 6.3M. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while YCBD trades at $0.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas YCBD's P/E ratio is -1.49. In terms of profitability, SIGA's ROE is -0.02%, compared to YCBD's ROE of -0.34%. Regarding short-term risk, SIGA is less volatile compared to YCBD. This indicates lower risk in terms of short-term price fluctuations for SIGA.Check YCBD's competition here
Gelteq Limited Ordinary Shares (NASDAQ: GELS)
SIGA vs GELS Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, GELS has a market cap of 5.2M. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while GELS trades at $0.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas GELS's P/E ratio is -1.14. In terms of profitability, SIGA's ROE is -0.02%, compared to GELS's ROE of -0.25%. Regarding short-term risk, SIGA is more volatile compared to GELS. This indicates higher risk in terms of short-term price fluctuations for SIGA.Check GELS's competition here
Mallinckrodt plc (AMEX: MNK)
SIGA vs MNK Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, MNK has a market cap of 4.5M. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while MNK trades at $0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas MNK's P/E ratio is -0.44. In terms of profitability, SIGA's ROE is -0.02%, compared to MNK's ROE of -0.36%. Regarding short-term risk, SIGA is less volatile compared to MNK. This indicates lower risk in terms of short-term price fluctuations for SIGA.Check MNK's competition here
Flora Growth Corp. (NASDAQ: FLGC)
SIGA vs FLGC Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, FLGC has a market cap of 4.2M. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while FLGC trades at $7.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas FLGC's P/E ratio is -0.19. In terms of profitability, SIGA's ROE is -0.02%, compared to FLGC's ROE of -3.03%. Regarding short-term risk, SIGA is less volatile compared to FLGC. This indicates lower risk in terms of short-term price fluctuations for SIGA.Check FLGC's competition here
Universe Pharmaceuticals Inc. (NASDAQ: UPC)
SIGA vs UPC Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, UPC has a market cap of 3.8M. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while UPC trades at $5.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas UPC's P/E ratio is -0.75. In terms of profitability, SIGA's ROE is -0.02%, compared to UPC's ROE of -0.03%. Regarding short-term risk, SIGA is less volatile compared to UPC. This indicates lower risk in terms of short-term price fluctuations for SIGA.Check UPC's competition here
Sunshine Biopharma, Inc. (NASDAQ: SBFM)
SIGA vs SBFM Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, SBFM has a market cap of 2.9M. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while SBFM trades at $1.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas SBFM's P/E ratio is -0.20. In terms of profitability, SIGA's ROE is -0.02%, compared to SBFM's ROE of -0.26%. Regarding short-term risk, SIGA is less volatile compared to SBFM. This indicates lower risk in terms of short-term price fluctuations for SIGA.Check SBFM's competition here
PLx Pharma Inc. (NASDAQ: PLXP)
SIGA vs PLXP Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, PLXP has a market cap of 2.5M. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while PLXP trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas PLXP's P/E ratio is -0.22. In terms of profitability, SIGA's ROE is -0.02%, compared to PLXP's ROE of -1.66%. Regarding short-term risk, SIGA is less volatile compared to PLXP. This indicates lower risk in terms of short-term price fluctuations for SIGA.Check PLXP's competition here
Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH)
SIGA vs SHPH Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, SHPH has a market cap of 2.5M. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while SHPH trades at $4.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas SHPH's P/E ratio is -0.20. In terms of profitability, SIGA's ROE is -0.02%, compared to SHPH's ROE of -4.08%. Regarding short-term risk, SIGA is less volatile compared to SHPH. This indicates lower risk in terms of short-term price fluctuations for SIGA.Check SHPH's competition here
Athenex, Inc. (NASDAQ: ATNX)
SIGA vs ATNX Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, ATNX has a market cap of 2.3M. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while ATNX trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas ATNX's P/E ratio is -0.02. In terms of profitability, SIGA's ROE is -0.02%, compared to ATNX's ROE of +0.22%. Regarding short-term risk, SIGA is more volatile compared to ATNX. This indicates higher risk in terms of short-term price fluctuations for SIGA.Check ATNX's competition here
Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA)
SIGA vs SNOA Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, SNOA has a market cap of 2.3M. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while SNOA trades at $1.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas SNOA's P/E ratio is -1.16. In terms of profitability, SIGA's ROE is -0.02%, compared to SNOA's ROE of -0.54%. Regarding short-term risk, SIGA is less volatile compared to SNOA. This indicates lower risk in terms of short-term price fluctuations for SIGA.Check SNOA's competition here
Procaps Group, S.A. (NASDAQ: PROCW)
SIGA vs PROCW Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, PROCW has a market cap of 2M. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while PROCW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas PROCW's P/E ratio is N/A. In terms of profitability, SIGA's ROE is -0.02%, compared to PROCW's ROE of -2.22%. Regarding short-term risk, SIGA is more volatile compared to PROCW. This indicates higher risk in terms of short-term price fluctuations for SIGA.Check PROCW's competition here
RedHill Biopharma Ltd. (NASDAQ: RDHL)
SIGA vs RDHL Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, RDHL has a market cap of 1.9M. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while RDHL trades at $0.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas RDHL's P/E ratio is 0.12. In terms of profitability, SIGA's ROE is -0.02%, compared to RDHL's ROE of +57.40%. Regarding short-term risk, SIGA is less volatile compared to RDHL. This indicates lower risk in terms of short-term price fluctuations for SIGA.Check RDHL's competition here
China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC)
SIGA vs SXTC Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, SXTC has a market cap of 1.8M. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while SXTC trades at $3.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas SXTC's P/E ratio is 1.18. In terms of profitability, SIGA's ROE is -0.02%, compared to SXTC's ROE of -0.31%. Regarding short-term risk, SIGA is less volatile compared to SXTC. This indicates lower risk in terms of short-term price fluctuations for SIGA.Check SXTC's competition here
cbdMD, Inc. (AMEX: YCBD-PA)
SIGA vs YCBD-PA Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, YCBD-PA has a market cap of 928.2K. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while YCBD-PA trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas YCBD-PA's P/E ratio is -2.69. In terms of profitability, SIGA's ROE is -0.02%, compared to YCBD-PA's ROE of -0.34%. Regarding short-term risk, SIGA is less volatile compared to YCBD-PA. This indicates lower risk in terms of short-term price fluctuations for SIGA.Check YCBD-PA's competition here
Cyclo Therapeutics, Inc. (NASDAQ: CYTHW)
SIGA vs CYTHW Comparison August 2026
SIGA Technologies, Inc. (NASDAQ: SIGA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SIGA stands at 205.8M. In comparison, CYTHW has a market cap of 928K. Regarding current trading prices, SIGA is priced at $2.91 on the NASDAQ, while CYTHW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SIGA currently has a P/E ratio of 10.63, whereas CYTHW's P/E ratio is N/A. In terms of profitability, SIGA's ROE is -0.02%, compared to CYTHW's ROE of -7.30%. Regarding short-term risk, SIGA is more volatile compared to CYTHW. This indicates higher risk in terms of short-term price fluctuations for SIGA.Check CYTHW's competition here